These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1316687)

  • 21. The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification.
    Imai K; Inoue H; Tamura M; Cueno ME; Inoue H; Takeichi O; Kusama K; Saito I; Ochiai K
    Biochimie; 2012 Mar; 94(3):839-46. PubMed ID: 22178321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase.
    Gao X; Ikuta K; Tajima M; Sairenji T
    Virology; 2001 Jul; 286(1):91-9. PubMed ID: 11448162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of the Epstein-Barr virus ZEBRA protein's capacity to disrupt latency by the addition of heterologous activation regions.
    Baumann R; Warren G; Askovic S
    Virology; 1995 Aug; 211(1):64-72. PubMed ID: 7645237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
    Gradoville L; Grogan E; Taylor N; Miller G
    Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
    Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
    Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
    Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
    J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
    Morrison TE; Kenney SC
    Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of amino acids in the DNA-recognition domain of Epstein-Barr virus ZEBRA protein alter its sub-nuclear localization and affect formation of replication compartments.
    Park R; Heston L; Shedd D; Delecluse HJ; Miller G
    Virology; 2008 Dec; 382(2):145-62. PubMed ID: 18937960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
    Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The mechanisms of Epstein-Barr virus activation in B cells].
    Sairenji T
    Nihon Rinsho; 1997 Feb; 55(2):316-20. PubMed ID: 9046817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M; Speck SH; Mulder C; Sairenji T
    Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of Epstein-Barr virus lytic replication by recombinant adenoviruses expressing the zebra gene with EBV specific promoters.
    Chen L; Yin J; Chen Y; Zhong J
    Acta Biochim Biophys Sin (Shanghai); 2005 Apr; 37(4):215-20. PubMed ID: 15806286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimerization of the Epstein-Barr virus ZEBRA protein in the yeast two-hybrid system. Comparison Of a ZEBRA variant with the B95-8 form.
    Martel-Renoir D; Wesner M; Joab I
    Biochimie; 2000 Feb; 82(2):139-45. PubMed ID: 10727769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latency.
    Baumann R; Grogan E; Ptashne M; Miller G
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4436-40. PubMed ID: 8389449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
    J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.